Point your AI agent at freehire and let it find you a job.

Get the CLI →

indivior

Develops pharmaceutical treatments for opioid use disorder and addiction.

H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion
biotechhealthcaremental-healthpharmaceuticals

Company facts

Founded
2014
Employees
1,000
Headquarters
United States
CEO
Mark Crossley
Type
Public
Listed
NASDAQ: INDV
Subsidiaries
Indivior Inc., Indivior Solutions, Opiant Pharmaceuticals

About

Indivior is a global pharmaceutical company that works tirelessly to change patients' lives by pioneering life-transforming treatments for substance use disorders and other serious mental illnesses. Founded as a division of Reckitt Benckiser in 1994 and becoming an independent entity in 2014, Indivior is dedicated to addressing the urgent public health crisis of opioid addiction through innovative medicines such as Sublocade and Suboxone. With over 20 years of experience in opioid addiction treatment, Indivior employs a patient-focused approach with an overarching vision that all patients around the world should have access to evidence-based treatment for chronic conditions associated with addiction. Indivior has made significant strides in advocating for patients by emphasizing the importance of early intervention and comprehensive treatment strategies. Their commitment to improving mental health services positions them at the forefront of the pharmaceutical industry in tackling addiction and promoting sustainable recovery solutions.

10 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available